Pinnacle Financial Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.31M | Sell |
18,886
-25,975
| -58% | -$1.8M | 0.03% | 259 |
|
|
2024
Q4 | $3.86M | Sell |
44,861
-21,912
| -33% | -$1.88M | 0.08% | 183 |
|
|
2024
Q3 | $7.95M | Buy |
66,773
+4,396
| +7% | +$523K | 0.16% | 140 |
|
|
2024
Q2 | $8.9M | Buy |
62,377
+57,478
| +1,173% | +$8.2M | 0.19% | 127 |
|
|
2024
Q1 | $629K | Buy |
4,899
+1,375
| +39% | +$177K | 0.01% | 306 |
|
|
2023
Q4 | $365K | Buy |
+3,524
| New | +$365K | 0.01% | 337 |
|
|
2016
Q4 | – | Sell |
-8,220
| Closed | -$227K | – | 266 |
|
|
2016
Q3 | $227K | Hold |
8,220
| – | – | 0.05% | 240 |
|
|
2016
Q2 | $227K | Buy |
+8,220
| New | +$227K | 0.05% | 232 |
|
|
2013
Q3 | – | Sell |
-16,250
| Closed | -$252K | – | 223 |
|
|
2013
Q2 | $252K | Buy |
+16,250
| New | +$252K | 0.13% | 117 |
|